Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Ottawa

$17,500.00

Determination of immunomodulatory bioactivity biomarkers in Wharton's Jelly MSCs

EF 2016-17

Résumé
Detrimental immune and inflammatory responses contribute to the pathogenesis of various conditions, including Crohn's disease, type 1 diabetes, and sepsis.1,2,3 Mesenchymal stromal cells (MSCs) are emerging as a promising cellular therapy for a variety of immune and inflammatory disorders because of their immunomodulatory functions, such as suppressing T cell proliferation.4,5,6 However, clinical trials that have employed MSC cellular therapies for various inflammatory diseases have produced varying and sometimes conflicting results.7,8,9,10 These discrepancies could be due to heterogeneity within MSC populations as well as the loss of immunosuppressive properties during the culture of MSC samples.8,10 The current lack of reliable biomarkers or standardized metrics to measure MSC immunomodulation makes identifying and bioprocessing effective therapeutic MSC populations difficult. I hypothesize that the immunomodulatory function of Wharton's Jelly MSC (WJ-MSC) can be accurately predicted through the detection of immunomodulatory biomarkers. The objective of my thesis is to discover biomarkers of WJ-MSC immunomodulatory bioactivity using unbiased omics analyses. Ultimately, we plan to integrate metrics for immunomodulation into a pipeline to identify, isolate and manufacture WJ-MSCs with the greatest immuno-modulatory function for use as a cellular therapy for immune and inflammatory diseases.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
367348
Name
Siriwardena Dylan
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Determination of immunomodulatory bioactivity biomarkers in Wharton's Jelly MSCs
Programtype2
Studentship Programs
Orgnameinp2
University of Ottawa
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Bioinformatics; Biomarkers; Immunomodulation; Mesenchymal Stromal Cells; Proteomics; Secretome; Sepsis; Transcriptomics
Abstract
Detrimental immune and inflammatory responses contribute to the pathogenesis of various conditions, including Crohn's disease, type 1 diabetes, and sepsis.1,2,3 Mesenchymal stromal cells (MSCs) are emerging as a promising cellular therapy for a variety of immune and inflammatory disorders because of their immunomodulatory functions, such as suppressing T cell proliferation.4,5,6 However, clinical trials that have employed MSC cellular therapies for various inflammatory diseases have produced varying and sometimes conflicting results.7,8,9,10 These discrepancies could be due to heterogeneity within MSC populations as well as the loss of immunosuppressive properties during the culture of MSC samples.8,10 The current lack of reliable biomarkers or standardized metrics to measure MSC immunomodulation makes identifying and bioprocessing effective therapeutic MSC populations difficult. I hypothesize that the immunomodulatory function of Wharton's Jelly MSC (WJ-MSC) can be accurately predicted through the detection of immunomodulatory biomarkers. The objective of my thesis is to discover biomarkers of WJ-MSC immunomodulatory bioactivity using unbiased omics analyses. Ultimately, we plan to integrate metrics for immunomodulation into a pipeline to identify, isolate and manufacture WJ-MSCs with the greatest immuno-modulatory function for use as a cellular therapy for immune and inflammatory diseases.
Competitiondate
201612
Approvedterm2
1 yr 0 mth
Pinamesdelim
Siriwardena, Dylan
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~